Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by robertshawon Sep 24, 2020 12:47pm
108 Views
Post# 31611913

RE:RE:SBRT and TLD-1433

RE:RE:SBRT and TLD-1433
Hankerchief wrote: enrique......years ago I harped on them considering going off shore (eg. Cayman Islands) to do studies on IV TLD 1433/Rutherrin with xray activation.  Nothing happened.  Nadda.   They have this jewel sitting there waiting to be used and nothing happens.  Sad for patients, their families, and yes, even us.  I'm strarting to feel like Richie Rich.  WTH?

enriquesuave wrote: A while back I had sent an email to several in management and suggested that they do a trial using SBRT and Rutherin for solid tumours such as GBM or NSCLC.  I believe they can significantly improve radiotherapy and achieve complete Tumor destruction or close, without having to perform any surgery or use of other hardware for standard PDT.  Especially for hard to reach tumours.  Used for all solid tumours everywhere in the body ( Brain, lung, prostate, liver, pancreas), SBRT is available practically everywhere and would be simple to perform and cheap to do a trial.  Teaming up with an X-ray equipment maker such as Siemens or other would be amazing. IMO.  I don't know if they are doing anything in that direction, but last NR they mentioned X-ray activation of Rutherin, and they have already done some animal study with X-ray activation.  With SBRT, one can precisely focus a much greater amount of X-ray dose on any Tumor using low radiation and safe for  nearby tissues.  Hope we eventually hear something about this. IMO.  https://www.mayoclinic.org/tests-procedures/sbrt/pyc-20446794




We know the management are all idiots, so why bother? As some one just posted on CEO. Ca/tlt, Dr. Sherry Ann Mcfarland just got the wrong partner who only care about their fat pay cheque....., If only all the long shareholders can unite and kick out of all the idiots out of the management
Bullboard Posts